# EDGAR Filing Document

**Accession Number:** 0002028735
**File Stem:** 0000000000-25-006177
**Filing Date:** 2025-6
**Character Count:** 6959
**Document Hash:** 9751693deb386e5205974ed67ff23c9c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006177.hdr.sgml**: 20250903

**ACCESSION NUMBER**: 0000000000-25-006177

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250612

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Silver Pegasus Acquisition Corp.
- **CENTRAL INDEX KEY:** 0002028735
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-07335

**BUSINESS ADDRESS:**
- **STREET 1:** 2445 AUGUSTINE DRIVE
- **STREET 2:** SUITES 150
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054
- **BUSINESS PHONE:** 408-734-6022

**MAIL ADDRESS:**
- **STREET 1:** 2445 AUGUSTINE DRIVE
- **STREET 2:** SUITES 150
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-24-061378

## Text-Extract

```

                                                              June 12, 2025

Cesar Johnston
Chairman, President and Chief Executive Officer
Silver Pegasus Acquisition Corp.
2445 Augustine Dr., STE 150
Santa Clara, CA 95054

       Re: Silver Pegasus Acquisition Corp.
           Amendment No.1 to Registration Statement on Form S-1
           Filed May 20, 2025
           File No. 333-284395
Dear Cesar Johnston:

     We have reviewed your amended registration statement and have the
following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

        After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our February 12,
2025
letter.

Amendment No.1 to Form S-1 filed May 20, 2025
Cover Page

1.     Please revise to clearly state that there may be actual or potential
material conflicts of
       interest between the sponsor, its affiliates, or promoters on the one
hand, and
       purchasers in the offering on the other hand. See Item 1602(a)(5) of
Regulation S-K.
2.     Please clarify whether the potential indirect purchase of private
placement warrants
       and founder shares by non-managing sponsor investors is conditioned upon
their
       purchase of units in the offering.
3.     Please disclose the number of non-managing sponsor members who have
expressed
       an interest in purchasing units. Please disclose whether there is a cap
on the amount
       that each investor may purchase. Please also disclose that the
non-managing sponsor
 June 12, 2025
Page 2

       investors will have the potential to realize enhanced economic returns
from their
       investment as compared to other investors purchasing in the offering.
Please also
       revise the summary to add back the disclosure regarding the expression
of interest
       and further clarify the potential impact such purchases could have upon
the trading
       volume, volatility and liquidity.
4.     We note your disclosure that non-managing Sponsor investors will have no
obligation
       to vote any of their public shares in favor of your initial business
combination, but that
       if they purchase all of the public units in which they have expressed
interest or
       otherwise hold a substantial number of public units they will
potentially have
       different interests than our other public shareholders    in approving a
business
       combination. It would appear that non-managing sponsor interests would
have
       different interests than public shareholders regardless of the number of
public shares
       they own due to their interest in founder shares and private placement
warrants. Please
       revise to clarify here and throughout the prospectus where you state
that non-
       managing Sponsor investors have no obligation to vote any public shares
in favor of a
       business combination.
Private Placements, page 14

5.     We note the disclosure regarding the ability of the Class B.2 warrant
holders to
       exchange their warrants for common stock based upon the formula
provided. Please
       reconcile with the cover page which states that "each private placement
warrant
       entitles the holder thereof to purchase one Class A ordinary share at a
price of $11.50
       per share." Please also provide some examples calculating the exchange
at various
       market prices and provide clear disclosure throughout to the extent such
exchange
       could result in material dilution.
Risk Factors
Risks Relating to our Management Team, page 73

6.     We note your disclosure on page 7 that in order to facilitate the
initial business
       combination your sponsor may surrender or forfeit, transfer, or exchange
founder
       shares, private placement warrants or any of its other securities,
including for no
       consideration, as well as subject any such securities to earn-outs or
other restrictions,
       or otherwise amend the terms of any such securities or enter into any
other
       arrangements with respect to any such securities. Please add risk factor
disclosure
       about risks that may arise from the sponsor having the ability to remove
itself as your
       sponsor before identifying a business combination, including through the
       unconditional ability to transfer the founder shares or otherwise.
General

7.     We note that this amendment reduces the amount of time the company has
to
       complete its initial business combination from 24 months to 18 months.
However, we
       continue to note numerous references to 24 months, such as in the
summary and risk
       factors. Please reconcile the time period within which the company has
to complete its
       initial business combination. Similarly, we note the anti-dilution
percentage of the
       sponsor shares in the table on page 4, 20%, is inconsistent with the
disclosure
       throughout the prospectus, which references 25%.
 June 12, 2025
Page 3

       Please contact Howard Efron at 202-551-3439 or Jennifer Monick at
202-551-3295 if
you have questions regarding comments on the financial statements and related
matters. Please contact Pearlyne Paulemon at 202-551-8714 or Pam Howell at
202-551-3357
with any other questions.

                                                        Sincerely,

                                                        Division of Corporation
Finance
                                                        Office of Real Estate &
Construction
cc:   Giovanni Caruso

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._